Antibiotics Mode Of Action And Mechanisms Of Resistance

  • Uploaded by: Mohamed
  • 0
  • 0
  • June 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Antibiotics Mode Of Action And Mechanisms Of Resistance as PDF for free.

More details

  • Words: 2,456
  • Pages: 53
Antibiotics: Mode of Action and resistance Antibiotic    

Chemical substance Natural, semi synthetic and wholly synthetic Effective at low concentration (μ/ml) Bacteria static or bactericidal Dr Ellabib MS

 Criteria for antibiotic  Selectively toxic for bacteria Bactericidal (killing) Bacteriostatic (growth inhibition)  No harm to patient  Destroy structures

Present in bacteria Not present in host  Antibiotics work together with immune system

 Minimal inhibitory concentration

 Lowest level stopping growth e.g. zone of inhibition around a disk impregnated with antibiotic Antibiotics inhibit cell wall are bactericidal Without cell wall osmotic pressure cause bacteria to burst

Mode of Action  Inhibitors of cell wall synthesis (Peptidoglycan)  Inhibit Peptidoglycan biosynthesis at various stages  Stage one: inhibit UDP –N-Acetylmuramic acid through inhibition of tranferase enzyme  Fosfomycin  Stage two: inhibit building pentapeptides side chain through inhibition of synthetase enzyme  Cycloserine  Stage three: inhibit reaction leading to formation of a linear Peptidoglycan polymer (pyrophosphtase enzyme)  Vancomycin & Bacitracin  Stage four: preventing cross-linking and formation of Peptidoglycan (transpeptidase enzyme)  Bound covalently to various proteins called penicillin binding proteins (PBPS)  B-lactam antibiotics

Chemical modification changes of Blactam and their biological activity  Early B-lactam antibiotics  Penicillin G &V  Inactive against gram negative  No penetration of outer membrane  Unstable to B-lactamases enzyme  Active against streptococcus pyogens

 Pencilliinase-resistant penicillin  More stable  Staphylococcus species  E.g. Methicillin and Oxacillin

 Aminopencillin  activity against gram positive  increased activity toward gram negative (E. coli)  Ampicillin, Amoxil

Antipseudomonase penicillin Carboxypenicillin Increased activity against -ve and decreased activity against +ve Carbenicillin and ticarcillin Uredopenicillin Increased activity against –ve and preserved activity against +ve Piperacillin and mezalocillin B-lactamases inhibitory Binds strongly to beta-lactamase Inhibit activity Called suicidal agents Clavulanic acid & Tazobactam

Cephalosporin's

 First generation  Old and narrow spectrum cephalosporin's  Cephaloridine, Cephalexin  2nd generation  -ve and some anaerobic bacteria  Cefuroxime and cefoxitin  3rd generation  -ve such as pseudomonas  Ceftriaxone and Ceftazidime  4th generation  Broad spectrum  cefpime

Other B-lactam antibiotics  Monobactams  -ve  Aztreonam  Carbapenems  -ve  Imipenem

Antifungal agents Antifungal  Chitin synthetase  Polyxin and nikkomycin  Glucan synthesis  cilofungin

Compounds inhibit cell membrane  Concentration dependent  Effect integrity of CM  Leakage of K, proteins and nucleic acid  Disinfectants, antiseptics and polypeptides  Phenols  Release compounds absorbed at 200nm  Inhibits electron transport chains (metabolic activity)  Alcohols  Interact with ester fatty acid and thiol group of proteins  Used as 70% concentration

Chlorohexidine

 Inhibit adenosine triphosphotase (ATPase)  Uptake of K+  Polymyxin B  Inhibit phospholipids of –ve but not +ve  Antifungal agents (inhibit Ergosterol)  Interact with phospholipids of CM directly  Pores and leakage  Amphotericin B and Nystatin  Indirectly inhibit ergosterol biosynthesis  Cytochrome P-450  Azoles antifungal (Miconazole, itraconazole, Clotrimazole )  Other non azoles such as terbifine morpholin and tolnaftate

Inhibitor of protein synthesis

 Mostly Bacteriostatic  Selectivity due to difference in ribosome's  Some toxicity –eukaryotic 70S ribosome's  Classes of ribosome's subunit  80s ribosome's (eukaryotic)  Dissociated to 60s and 40s as Mg+ concentration  Protein to RNA (50:50)  70s (prokaryotic and eukaryotic)  dissociate to 30s and 50s  Protein to RNA (35:65)  50-55s ribosome's (mammalian mitochondria)

Antimicrobial that bind to the 30s Amino glycosides  Such as Streptomycin, gentamicin, Amikacin  Gram positive and –Ve  Slight initial entry of the drug inside cell  Interact with chain elongation (PC) at 12s  Misreading of mRNA abnormal protein  formation of abnormal channels  Increase and irreversible entry through channels  Blockage initiation of ribosome's  Inhibit binding of aminoacyl-tRNA and peptide synthesis inhibit protein synthesis

Tetracycline's ( Rickettsias and mycoplasma) Short acting Chlortetracycline Intermediate Demeclocycline Long acting Doxycycline Blocking binding of aminoacyl-tRNA acceptor site on the mRNA ribosome's complex Prevent the addition of new amino acids to the growing peptide chain

Antimicrobials bound to 50s subunit

Chloramphenicol  Natural antibiotic  Meningitis, typhoid fever  Associated with bone marrow toxicity  Reversible effect  Bind to a region on 50s close to site bound aminoacyl-tRNA in peptidyltransferase center  Blocking addition of new amino acids  Prevent growing of protein chain  Inhibit peptide bound formation

Macrolides (erythromycin, claritromycin and spiramycin)  +ve bacteria, mycoplasma, legionella  Resistant common  Stimulate dissociation of peptidy-tRNA from ribosome's during translocation step  Interrupting completion of peptide chain formation

Lincosamides (Lincomycin & Clindomycin)  Similar to chloramphenicol and erythromycin  +ve cocci  Resistant common  Anaerobic bacteria

Inhibitors of protein synthesis

Fusidic acid

Bind to 70s ribosome's Active against gram positive cocci Inhibits polypeptide chain elongation

Inhibitor of nucleic acid synthesis  To toxic  Some are used to treat tumor, viral and serious bacterial such as TB  DNA inhibition  result in cell division inhibition  Effect Extra chromosomal elements of DNA and plasmids  Effect bacterial response to environmental changes  RNA inhibition  Inhibit protein synthesis

Nucleic acid inhibitors (Two groups)

 Compound interfere with precursor of nucleic acid (purine, pyrimidine) Sulfonamides and trimethoprim Compounds interfere with nucleic acid synthesis at the polymerization stage

RNA polymerase inhibitors

 rifampin Mycobacterium tuberculosis Inhibit DNA-dependent RNA polymerase RNA polymerase

Minimal or core enzyme

α, β, β1 and ω subunits

Sigma factor (RNA)

Rifampin continuous  Form a tight one to one complex with β subunit  Prevent protein synthesis (chain initiation)  DNA gryases or topoisomerase inhibitors  quinolones  Nalidixic acid, ciprofloxacin  Called nick closing enzyme  Enzyme play important role in supercoil strand DNA  Supercoiling is completed the single strand DNA is abolished by an enzyme that seals the nicked DNA  The enzyme is known as DNA gryase or Topoisomerase 2

DNA gryase or Topoisomerase 2 Four subunits and two were identified as A and β  A subunit introduce the nick and seal the nick they produced initially Nalidixic acid  β subunit Responsible for supercoil Norofloxacin & ciprofloxacin May interfere with A and β subunit

Inhibitors of Folic Acid Synthesis

 Sulfonamides  Trimethoprim

Anti- Mycobacterial Antibiotics Para-aminosalicylic acid (PSA) Para-aminosalicylic  Bacteriostatic

 Dapsone  Bacteriostatic

 treatment of leprosy (Mycobacterium leprae)

 Isoniazid (INH)  bacteriostatic  inhibits synthesis of mycolic acids.

Furantoin  Gram positive and negative  Urinary tract infection  Damaging DNA Nitro-imidazole (metronidazole)  Anaerobic bacteria and protozoa  Reduced to Nitro radical compounds  Acts as nuclease and damaging DNA Griseofulvin  Antifungal agent  Dermatophytes infection only  Effect nuclear function  Interfere with microtubules during separation of chromosomes in cell division at the metaphase

Antibiotic Mechanisms of Action

Microbial resistance to antimicrobial agents  Clinical resistance  By mutation or acquisition of a plasmid  Provides a selective advantage  Single or multiple steps

 Cross resistance Vs multiple resistance  Cross resistance  single mutation  closely related antibiotics  Multiple resistance  multiples mechanisms  Unrelated antibiotics

Genetic basis of resistance

Mutation  For the origin of some resistant variants

Acquisition  Transfer of genetics material from R to S microorganism  Confined by genes on Chromosomal or plasmid

 Chromosomal mediated resistant  Remain with the particular bacterial cell  And Offspring

 Plasmid mediated resistant  Self replicating extra chromosomal DNA  Widely distributed in nature  Often transmissible  Often Carry resistant determinants to many drugs

 Other function of plasmid  Carry genes allow bacteria to attach to mucosal surface  Produce toxins  Invade and colonize host cells

Transformation of plasmid resistant  Conjugation (direct cell to cell contact)  Transduction (bacteriophage vector)  Transformation (uptake DNA from environment)  Transposition (transformation via transposons

Transduction ( bacteriophages vector)

 Transposons  So called jumping genes  Movable DNA elements  Carrying resistant genes  Jump or hop from plasmid to plasmid  From plasmid to chromosomal  Found in many bacteria  Carrying resistant to many antibiotic  Main cause of hospital and community outbreaks resistant

 Plasmid from Epidemiological

viewpoint  Most important type of resistant  Transmissible  Usually highly stable  Convert resistant to different class of antibiotics  Often associated with other characteristics  Requirements for antibiotic activity and mechanisms resistant

 Properties of antibiotic required for efficacy  Penetration to target site in sufficient amount  Evade inactivation enzymes by microorganism  Interaction with target molecules to initiate an effect

Steps of resistant mechanisms  Cellular barrier to drug penetration  Reduce antibiotic activity  Altered target molecules  Interact less effectively with drug with retain function  May use additional pathway insensitive to the drug  Modifying or inactivating enzymes  Rendering antibiotic ineffective Two or more of these mechanisms give rise to high level of resistant than any one mechanisms alone

Resistant due to permeability  Beta lactam  Poor permeability

 change in porin channels  Mutation  Such as Neisseria gonorrhoeae

 Outer membrane composition

 Lipoplysaccharides, lipids and proteins  Pseudomonas aeruginosa  Usually display resistant to other antibiotics E. coli deficient mutant in porin channels  Was sensitive to imipenem because  Due to its compact zwitterionic structure  Permit rapid penetration  PBP2 per cell 20  Require only few drug molecules for antimicrobial

Aminoglycosides  loss or reduction in outer membrane proteins  Enterobacteriacae  Appearance of new outer membrane proteins  Or alteration in surface Lipoplysaccharides  Affect intracellular uptake of Aminoglycosides  Ps. aeruginosa  MLS Antimicrobials  Intrinsic low level resistant to erythromycin  Limited drug permeability  Enterobacteriacae  Reduced drug uptake  Staph. epidermidis  Chloramphenicol  Loss of outer membrane proteins  Diminish uptake of drug in Ps. aeruginosa (acquired)

 Tetracycline's  Poor penetration  Change in outer membrane (proteins, porin)  Alteration in Lipoplysaccharides  Ps. Aeruginosa (intrinsic)  Poor penetration  plasmid-mediated changes in transport system  Acquired  Anaerobic bacteria

 Quinolones  Decrease level of major outer membrane proteins  Enterobacteriacae  Cross resistant with unrelated antibiotics

Folate pathway inhibitors  Permeability barriers  Intrinsically  Ps. aeruginosa  Trimethoprim  Acquired  Diminished level of putative proteins  Enterobacteriacae  Trimethoprim  Cross resistant to other unrelated drugs classes  Decrease intracellular penetration  Intrinsic or acquired  Gram negative bacteria  sulphonamides



Resistant due to altered target molecules  Beta-lactam antibiotics  Altered penicillin-binding proteins (PBPS)  Pneumococci  Staph. aureus  Methicillin Resistant Staph. aureus (MRSA)  PBP2 alteration  Lower affinity to drug  Resistant gene located on transposable genetic element  Should be consider resistant to all beta-lactam drugs

 Aminoglycosides  Mutation affecting binding to ribosomal target  Streptomycin and kanamycin  Alteration of 12s protein  Control binding of drugs to 30s ribosomal subunit  Staph. aureus, Ps. aeruginosa and mycobacterium

Macrolides-Lincosamides

 Barrier to penetration  Intrinsic In Enterobacteriacae  Alteration in 50s ribosomal subunit  Plasmid-mediated  Found on transposons  Staph. aureus., streptococci, Pneumococci, Bacteroides  Demethylation of adenine group of 23s rRNA  Decrease binding to 50s ribosomal subunit

Continuous  Inducible or constitutive

 Inducible bacteria  Show resistant to erythromycin and sensitive to Clindomycin  Sub inhibitory concentration of erythromycin  Increase methylase enzyme  Induced cells became resistant to all MLS

 Constitutive cell  Resistant to MLS without prior antibiotic exposure

Quinolones  Mutation in DNA gryase A and B subunit  E. coli  Rifampin  Single step mutation in B-subunit RNA polymerase  E. coli  Folate pathway inhibitors  Low affinity to dihydropteroate synthetase  Hyper production of enzyme  Gram negative bacteria  Transposons  sulphonamide

Folate pathway inhibitors  Low affinity to dihydrofolate reductase  Hyper production of enzyme  Trimethoprim

Resistant due to inactivation of antimicrobial Beta-lactam antibiotics  Most common and understand mechanisms  Dozens of enzymes  Differing in their substrate profile  Potential for inhibition by B-lactam inhibitors  Physical characteristics  Divided into Four groups based on  Preferred antibiotic substrate  Inhibition by Clavulanic acid  Based on Bush Scheme classification

Classification schemes of Bush Enzyme class OR Groups characteristic One

Example

cephalosporinase not inhibited chromosomal enzyme of Ps. by Clavulanic acid aeruginosa and Ent. Cloacae 2a-2c Pencilliinases and cephalosporinase plasmid mediated Temtype inhibited by Clavulanic acid Staph, Kleb, chromosm Group 3 Metalloenzymes Imipenem hydrolyzing enzyme of Ps. Maltophilia Group 4 Pencilliinases not inhibited chromosom enzyme of Clavulanic acid Ps. Cepacia

Gram positive bacteria  Presented by exoenzyme of Staph, Enterococcus  Less active against cephalosporin and stable penicillin's  Inhibited by Clavulanic acid NB: Border line Oxacillin resistant (hyper producer of enzyme)  Gram-negative bacteria  Many has been described  Plasmid or chromosomal mediated  Common among nosocomial pathogens  Enterobacteriacae  Ps. aeruginosa and Acinetobacter spp

Plasmid-mediated Blactamase

Such as TEM (Hydrolyzing ampicillin) TEM3 (CTX) hydrolyzing cefotaxime TEM5 (CAZ) hydrolyzing Ceftazidime Inhibited by B-lactamase inhibitors Inducible chromosomally-mediated  Produced at low concentration before antibiotic exposure  Hyper production after exposure  Resistant to many B-lactam antibiotics  Ps. aeruginosa, Enterobacter

Aminoglycosides      

Acetylation of amino groups Adenylation Phosphorylation of hydroxyl group Plasmid or chromosomal modifying enzymes Enzyme may be located on transposons Staph. aureus or Ps. Aeruginosa

 MLS  Esterase enzyme  Plasmid born  Klebseilla pneumoniae  E. coli  Erythromycin

Chloramphenicol  Drug inactivation by enzyme  Major mechanisms of resistant  Gram positive bacteria  By acetyltransferase enzyme  Plasmid and inducible in Staph. aureus and Enterococci  Constitutive in gram negative and plasmid located on transposons  Anaerobic bacteria  Enzyme identified as nitroreductase  Bacteroides fragilis

Tetracycline's  Transposons element mediated resistant  Promoting active drug efflux  Drug detoxification  Bacteroides fragilis Notes: active efflux I a mechanism involving certain protein by which the cell pumping the drug out

Antimicrobial cross resistant  Between drugs from same class  Beta-lactam (MRSA)  Aminoglycosides  Inactivating enzymes  Ps aeruginosa  MLS  Staph. Aureus  Different classes  Permeability mutant  Altered outer membrane protein

Different classes

 Gram negative bacteria  Quinolones, trimethoprim, chloramphenicol  Single or many plasmids  Resistant to multiple classes of antibiotics  Reduction of antimicrobial resistant and synergism  Synergism  Two drug combined together  0.25 of MIC of each drug  Exert higher activity than that achieved by each drug alone  Used to prevent resistant  Rifampin and streptomycin for TB

Continuous  Rifampin plus Vancomycin for endocarditis  B-lactam plus aminoglycosides for –ve  Amphotericin B plus 5-flourocytosine for Cryptococcus neoformans  Empirical for unknown organisms or mixed infection  Metronidazole plus gentamicin

Related Documents


More Documents from ""

Carte D'afrique.pdf
April 2020 2
Dr.tarek Suwaidan
November 2019 18
Pml001-1018
May 2020 5
Entretien.docx
June 2020 1